Echocardiographic Standards and Sub-Saharian Africans (SSA) Migrants' in New Aquitaine Region
NEMANA
1 other identifier
interventional
100
1 country
1
Brief Summary
Standards Echocardiographic have been defined mainly on caucasian or Asian populations. In the EchoNoRMAL study the criteria for African populations were based solely on data from 198 subjects. This study suggests the presence of different standards depending on the ethnic origin of the subjects. The aims of this study is to describe the proportion of subjects reclassified (normal-pathological) according to the use of echocardiographic norm differences showed in TAHES population (Sub Saharian Africans) with those routinely used
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2021
CompletedFirst Posted
Study publicly available on registry
April 29, 2021
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2022
CompletedApril 29, 2021
April 1, 2021
1.3 years
April 15, 2021
April 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of subjects reclassified (from pathological to normal) according to the echocardiographic standard used (reference standard vs. TAHES standard).
Compare the echocardiography standards previously established in TAHES study to those used routinely managed for the population of SSA migrants in la region New Aquitaine, in order to define pathological subjects
18 months
Secondary Outcomes (1)
Describe the reasons of reclassification, based on the change of echocardiography standards use for the following criteria: left ventricular hypertrophy, left atrial dilatation, aortic dilatation, ascending, right ventricular dilatation
18 months
Study Arms (1)
African migrant's population located in la region New Aquitaine.
EXPERIMENTALEchocardiography norms will be harvested data on SSA participants located in la region New Aquitaine, France
Interventions
Upon SSA Subject is admitted to the hospital for an echocardiography, * Information about this study process, * Participants will receive an information note ; * Administration of a medical history questionnaire, collection of cardiovascular risk factors, weight toe (all of which are routinely collected before an echocardiographic examination is performed); * Performing and recording the echocardiographic examination according to routine protocol * delivery of the results according to the usual management; * deferred analysis of the recordings on workstation with classification of the data (normal-pathological) according to the different standards
Eligibility Criteria
You may qualify if:
- \- SSA Major Subjects (first generation or from or from first generation parents) admitted to the hospital for an echocardiography
You may not qualify if:
- Participation refusal;
- Any acute heart disease (endocarditis, myocarditis, coronary syndrome);
- Valvulopathy justifying an intervention;
- Diseases of overload.
- Any acute heart disease (endocarditis, myocarditis, coronary syndrome);
- Valvulopathy justifying an intervention;
- Diseases of overload.
- Both participant and accompanying person unable to understand the information note written in French and in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Limogeslead
- University Hospital, Bordeauxcollaborator
Study Sites (1)
Explorations fonctionnelles vasculaires et angiologie (Hôpital Dupuytren)
Limoges, 87000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe Lacroix, Professor
0033555056391
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2021
First Posted
April 29, 2021
Study Start
June 1, 2021
Primary Completion
September 15, 2022
Study Completion
September 15, 2022
Last Updated
April 29, 2021
Record last verified: 2021-04